Published in Eur J Biochem on February 15, 1995
Sequential steps in human immunodeficiency virus particle maturation revealed by alterations of individual Gag polyprotein cleavage sites. J Virol (1998) 3.84
The spacer peptide between human immunodeficiency virus capsid and nucleocapsid proteins is essential for ordered assembly and viral infectivity. J Virol (1995) 3.80
Protein kinase B regulates T lymphocyte survival, nuclear factor kappaB activation, and Bcl-X(L) levels in vivo. J Exp Med (2000) 2.51
N-Terminal extension of human immunodeficiency virus capsid protein converts the in vitro assembly phenotype from tubular to spherical particles. J Virol (1998) 2.49
Actin associates with the nucleocapsid domain of the human immunodeficiency virus Gag polyprotein. J Virol (1999) 1.59
Cleavage of human immunodeficiency virus type 1 proteinase from the N-terminally adjacent p6* protein is essential for efficient Gag polyprotein processing and viral infectivity. J Virol (1998) 1.25
Importance of protease cleavage sites within and flanking human immunodeficiency virus type 1 transframe protein p6* for spatiotemporal regulation of protease activation. J Virol (2008) 1.14
Systematic mutational analysis of the active-site threonine of HIV-1 proteinase: rethinking the "fireman's grip" hypothesis. Protein Sci (2000) 0.92
HIV type 1 Gag virus-like particle budding from spheroplasts of Saccharomyces cerevisiae. Proc Natl Acad Sci U S A (2002) 0.90
Characterization of the protease of a fish retrovirus, walleye dermal sarcoma virus. J Virol (2002) 0.86
Comparative studies on retroviral proteases: substrate specificity. Viruses (2010) 0.85
Induced maturation of human immunodeficiency virus. J Virol (2014) 0.81
Reverse transcription complex: the key player of the early phase of HIV replication. Future Virol (2007) 0.80
In vitro analysis of human immunodeficiency virus particle dissociation: gag proteolytic processing influences dissociation kinetics. PLoS One (2014) 0.78
A segment of the 5' nontranslated region of encephalomyocarditis virus RNA directs internal entry of ribosomes during in vitro translation. J Virol (1988) 13.93
Purification and further properties of single-strand-specific nuclease from Aspergillus oryzae. Eur J Biochem (1973) 13.54
Generation of avian myeloblastosis virus structural proteins by proteolytic cleavage of a precursor polypeptide. J Mol Biol (1975) 6.84
Self-assembly in vitro of purified CA-NC proteins from Rous sarcoma virus and human immunodeficiency virus type 1. J Virol (1995) 5.21
Poliovirus proteinase 2A induces cleavage of eucaryotic initiation factor 4F polypeptide p220. J Virol (1987) 4.52
Properties of avian retrovirus particles defective in viral protease. J Virol (1990) 4.03
Sequential steps in human immunodeficiency virus particle maturation revealed by alterations of individual Gag polyprotein cleavage sites. J Virol (1998) 3.84
The spacer peptide between human immunodeficiency virus capsid and nucleocapsid proteins is essential for ordered assembly and viral infectivity. J Virol (1995) 3.80
A large deletion in the matrix domain of the human immunodeficiency virus gag gene redirects virus particle assembly from the plasma membrane to the endoplasmic reticulum. J Virol (1993) 3.75
Cryo-electron microscopy reveals ordered domains in the immature HIV-1 particle. Curr Biol (1997) 3.59
In vitro assembly properties of purified bacterially expressed capsid proteins of human immunodeficiency virus. Eur J Biochem (1997) 3.38
The hepatitis C virus nonstructural protein 4B is an integral endoplasmic reticulum membrane protein. Virology (2001) 3.25
Characterization of the single-strand-specific nuclease S1 activity on double-stranded supercoiled polyoma DNA. Eur J Biochem (1974) 3.24
Identification of retrovirus matrix proteins by lipid-protein cross-linking. J Mol Biol (1979) 3.21
Identification of a large polypeptide precursor of avian oncornavirus proteins. Proc Natl Acad Sci U S A (1973) 3.07
Poliovirus polypeptide precursors: expression in vitro and processing by exogenous 3C and 2A proteinases. Proc Natl Acad Sci U S A (1987) 2.98
Subcellular localization, stability, and trans-cleavage competence of the hepatitis C virus NS3-NS4A complex expressed in tetracycline-regulated cell lines. J Virol (2000) 2.89
Analysis of HIV particle formation using transient expression of subviral constructs in mammalian cells. Virology (1992) 2.88
A conformational switch controlling HIV-1 morphogenesis. EMBO J (2000) 2.86
Biochemical and structural analysis of isolated mature cores of human immunodeficiency virus type 1. J Virol (2000) 2.80
In vitro cleavage of avian retrovirus gag proteins by viral protease p15. Virology (1979) 2.64
The biosynthesis of oncovirus proteins. Biochim Biophys Acta (1978) 2.57
Synthesis of avian RNA tumor virus structural proteins. Cold Spring Harb Symp Quant Biol (1975) 2.55
Human immunodeficiency virus type 1 Nef protein is incorporated into virus particles and specifically cleaved by the viral proteinase. Virology (1996) 2.50
N-Terminal extension of human immunodeficiency virus capsid protein converts the in vitro assembly phenotype from tubular to spherical particles. J Virol (1998) 2.49
A block to human immunodeficiency virus type 1 assembly in murine cells. J Virol (2000) 2.47
Organization of immature human immunodeficiency virus type 1. J Virol (2001) 2.34
A mobile group I intron in the nuclear rDNA of Physarum polycephalum. Cell (1989) 2.28
Mobile introns: definition of terms and recommended nomenclature. Gene (1989) 2.26
Ubiquitin in avian leukosis virus particles. Virology (1990) 2.13
Proteolytic processing of polyproteins in the replication of RNA viruses. Biochemistry (1989) 2.04
Purification and properties of an aminopeptidase from Escherichia coli. J Biol Chem (1970) 2.02
Structure and processing of the p2 region of avian sarcoma and leukemia virus gag precursor polyproteins. J Virol (1986) 1.93
Structure of ribosomal DNA in Physarum polycephalum. J Mol Biol (1976) 1.92
The NH2-terminal sequence of the avian oncovirus gag precursor polyprotein (Pr76gag). Virology (1978) 1.90
Fine-structure analyses of lipid-protein and protein-protein interactions of gag protein p19 of the avian sarcoma and leukemia viruses by cyanogen bromide mapping. J Virol (1984) 1.90
Characterization of Rous sarcoma virus Gag particles assembled in vitro. J Virol (2001) 1.85
Chemical crosslinking of proteins in avian sarcoma and leukemia viruses. Virology (1980) 1.83
Structure and self-association of the Rous sarcoma virus capsid protein. Structure (2000) 1.83
Active foamy virus proteinase is essential for virus infectivity but not for formation of a Pol polyprotein. J Virol (1995) 1.81
Characterization of I-Ppo, an intron-encoded endonuclease that mediates homing of a group I intron in the ribosomal DNA of Physarum polycephalum. Mol Cell Biol (1990) 1.75
Virion incorporation of human immunodeficiency virus type 1 Nef is mediated by a bipartite membrane-targeting signal: analysis of its role in enhancement of viral infectivity. J Virol (1998) 1.72
Context dependence of different modules for posttranscriptional enhancement of gene expression from retroviral vectors. Mol Ther (2000) 1.71
Efficiency and selectivity of RNA packaging by Rous sarcoma virus Gag deletion mutants. J Virol (1994) 1.70
Sensitive, soluble chromogenic substrates for HIV-1 proteinase. J Biol Chem (1990) 1.70
Genetic determinants of Rous sarcoma virus particle size. J Virol (1998) 1.67
Primary structure of p19 species of avian sarcoma and leukemia viruses. J Virol (1985) 1.61
RNA-binding properties of the matrix protein (p19gag) of avian sarcoma and leukemia viruses. J Virol (1990) 1.59
Mouse-human heterokaryons support efficient human immunodeficiency virus type 1 assembly. J Virol (2001) 1.55
The replication of ribosomal DNA in Physarum polycephalum. Eur J Biochem (1977) 1.55
Human immunodeficiency virus type 1 Vpr protein is incorporated into the virion in significantly smaller amounts than gag and is phosphorylated in infected cells. J Virol (2000) 1.54
Nucleotide sequence and protein analysis of a complex piscine retrovirus, walleye dermal sarcoma virus. J Virol (1995) 1.47
Avian sarcoma virus gag precursor polypeptide is not processed in mammalian cells. J Virol (1982) 1.46
Differential proteolytic processing leads to multiple forms of the CA protein in avian sarcoma and leukemia viruses. J Virol (1995) 1.45
trans-acting viral protease is necessary and sufficient for activation of avian leukosis virus reverse transcriptase. J Virol (1991) 1.45
Role of the Rous sarcoma virus p10 domain in shape determination of gag virus-like particles assembled in vitro and within Escherichia coli. J Virol (2000) 1.40
In vitro assembly properties of wild-type and cyclophilin-binding defective human immunodeficiency virus capsid proteins in the presence and absence of cyclophilin A. Virology (1999) 1.37
Synthetic peptides as substrates and inhibitors of human immune deficiency virus-1 protease. J Biol Chem (1988) 1.35
Different requirements for productive interaction between the active site of HIV-1 proteinase and substrates containing -hydrophobic*hydrophobic- or -aromatic*pro- cleavage sites. Biochemistry (1992) 1.33
Multiple copies of the Mason-Pfizer monkey virus constitutive RNA transport element lead to enhanced HIV-1 Gag expression in a context-dependent manner. Nucleic Acids Res (2000) 1.32
Proteolytic activity of novel human immunodeficiency virus type 1 proteinase proteins from a precursor with a blocking mutation at the N terminus of the PR domain. J Virol (1994) 1.30
Purification and properties of a fifth major viral gag protein from avian sarcoma and leukemia viruses. J Virol (1983) 1.26
Epitope mapping of monoclonal antibodies to gag protein p19 of avian sarcoma and leukaemia viruses. J Gen Virol (1987) 1.26
A possible regulation of negative factor (Nef) activity of human immunodeficiency virus type 1 by the viral protease. Eur J Biochem (1994) 1.26
The organization of mature Rous sarcoma virus as studied by cryoelectron microscopy. J Struct Biol (2001) 1.26
Cleavage of human immunodeficiency virus type 1 proteinase from the N-terminally adjacent p6* protein is essential for efficient Gag polyprotein processing and viral infectivity. J Virol (1998) 1.25
An intron in the nuclear ribosomal DNA of Didymium iridis codes for a group I ribozyme and a novel ribozyme that cooperate in self-splicing. Cell (1994) 1.24
Purification and properties of S1 nuclease from Aspergillus. Methods Enzymol (1980) 1.22
Analysis of hepatitis C virus core protein interaction domains. J Gen Virol (1997) 1.21
Interaction of the intron-encoded mobility endonuclease I-PpoI with its target site. Mol Cell Biol (1993) 1.21
Mutational analysis of a native substrate of the human immunodeficiency virus type 1 proteinase. J Virol (1990) 1.19
Processing of avian retroviral gag polyprotein precursors is blocked by a mutation at the NC-PR cleavage site. J Virol (1992) 1.18
Structural and functional studies in vitro on the p6 protein from the HIV-1 gag open reading frame. Biochim Biophys Acta (1993) 1.18
A mouse homolog to the avian sarcoma virus src protein is a member of a protein kinase cascade. Cell (1981) 1.13
Cyclophilin A incorporation is not required for human immunodeficiency virus type 1 particle maturation and does not destabilize the mature capsid. Virology (1999) 1.13
Competitive inhibition of human immunodeficiency virus type-1 protease by the Gag-Pol transframe protein. J Biol Chem (1999) 1.11
Two group I ribozymes with different functions in a nuclear rDNA intron. EMBO J (1995) 1.10
Structure of the central spacer region of extrachromosomal ribosomal DNA in Physarum polycephalum. J Mol Biol (1982) 1.07
In vivo selection of Rous sarcoma virus mutants with randomized sequences in the packaging signal. J Virol (1998) 1.07
Analysis of Rous sarcoma virus Gag protein by mass spectrometry indicates trimming by host exopeptidase. J Virol (1996) 1.05
Characterization of the human endogenous retrovirus K proteinase. J Gen Virol (1996) 1.05
Amino-terminal amino acid sequence of p10, the fifth major gag polypeptide of avian sarcoma and leukemia viruses. J Virol (1983) 1.04
Assignment of the 1H nuclear magnetic resonance spectrum of the proteinase inhibitor IIA from bull seminal plasma by two-dimensional nuclear magnetic resonance at 500 MHz. J Mol Biol (1983) 1.02
A mobile group I intron from Physarum polycephalum can insert itself and induce point mutations in the nuclear ribosomal DNA of saccharomyces cerevisiae. Mol Cell Biol (1993) 1.02
Characterization of the self-splicing products of a mobile intron from the nuclear rDNA of Physarum polycephalum. Nucleic Acids Res (1992) 1.00
Naegleria nucleolar introns contain two group I ribozymes with different functions in RNA splicing and processing. RNA (1997) 1.00
An engineered retroviral proteinase from myeloblastosis associated virus acquires pH dependence and substrate specificity of the HIV-1 proteinase. EMBO J (1992) 0.98
Chromophoric and fluorophoric peptide substrates cleaved through the dipeptidyl carboxypeptidase activity of cathepsin B. Anal Biochem (1987) 0.98
Loss of N-linked glycans in the V3-loop region of gp120 is correlated to an enhanced infectivity of HIV-1. Glycobiology (2001) 0.97
Characterization of a telomere-binding protein from Physarum polycephalum. Mol Cell Biol (1991) 0.95